億帆醫藥(002019.SZ):全資公司再次通過高新技術企業認定
格隆匯 1 月 11日丨億帆醫藥(002019.SZ)公佈,公司全資公司安慶市鑫富化工有限責任公司(“安慶鑫富”)於近日收到由安徽省科學技術廳、安徽省財政廳、國家税務總局安徽省税務局聯合頒發的《高新技術企業證書》。
此次認定系原《高新技術企業證書》有效期滿後進行的重新認定。根據《高新技術企業認定管理辦法》、《中華人民共和國企業所得税法》等相關規定,重慶鑫富可連續三年(2020年-2022年)享受國家關於高新技術企業所得税的優惠政策,即按15%的税率繳納企業所得税。
2020年度,安慶鑫富已按照15%的企業所得税税率進行納税申報及預繳,此次高新技術企業的認定事項不會影響公司2020年度的相關財務數據,對公司後續年度的經營業績將產生一定的積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.